DUBLIN--(http://www.researchandmarkets.com/research/mwzt9c/global_human) has announced the addition of the "Global Human Papillomavirus Drug Pipeline Capsule - 2012 Update" report to their offering.)--Research and Markets (
“Global Human Papillomavirus Drug Pipeline Capsule - 2012 Update”
Fore Pharma's latest report 'Global Human Papillomavirus Drug Pipeline Capsule - 2012 Update' provides most up-to-date information on key Research and Development activities (R&D) in the global Human Papillomavirus market. It covers active Human Papillomavirus pipeline molecules in various stages of clinical trials, preclinical research, and drug discovery.
This report helps executives track competitors pipeline molecules. The information presented in this report can be used for identifying partners, evaluating opportunities, formulating business development strategies, executing in-licensing and out-licensing deals.
The report provides information on pipeline molecules by company and mechanism of action across the R&D stages. It also provides information on pipeline molecules developed in leading geographies (North America and Europe). Licensing activities are thoroughly captured in this report.
Key Topics Covered:
1. Human Papillomavirus - Disease Overview
2. Human Papillomavirus Pipeline Overview
3. Human Papillomavirus Phase 3 Clinical Trial Pipeline Insights
4. Human Papillomavirus Phase 2 Clinical Trial Pipeline Insights
5. Human Papillomavirus Phase 1 Clinical Trial Pipeline Insights
6. Human Papillomavirus Preclinical Research Pipeline Insights
7. Human Papillomavirus Discovery Stage Pipeline Insights
8. Human Papillomavirus Drug Development Activities - Geographic Landscape
8.1. Human Papillomavirus R&D Activities in North America
8.2. Human Papillomavirus R&D Activities in Europe
9. Human Papillomavirus Pipeline - Licensing Activities
For more information visit http://www.researchandmarkets.com/research/mwzt9c/global_human